Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99

1.

Management strategies of academic pigmented lesion clinic directors in the United States.

Nelson KC, Grossman D, Kim CC, Chen SC, Curiel-Lewandrowski CN, Grichnik JM, Kirkwood JM, Leachman SA, Marghoob AA, Swetter SM, Venna SS, Ming ME.

J Am Acad Dermatol. 2018 Aug;79(2):367-369. doi: 10.1016/j.jaad.2017.12.069. Epub 2018 Jan 4. No abstract available.

PMID:
29307637
2.

PD1 inhibitors and hair repigmentation: A desirable new side effect.

Correa-Selm LM, Grichnik JM.

Dermatol Ther. 2018 Jan;31(1). doi: 10.1111/dth.12560. Epub 2017 Oct 15. No abstract available.

PMID:
29034554
3.

Prevention of graying: Is KROX20 the solution?

Correa-Selm LM, Grichnik JM.

Dermatol Ther. 2017 Sep;30(5). doi: 10.1111/dth.12534. Epub 2017 Aug 10. No abstract available.

PMID:
28796343
4.

Optical Coherence Tomography Visualization of a Port-Wine Stain in a Patient With Sturge-Weber Syndrome.

Aldahan AS, Chen LL, Tsatalis JP, Grichnik JM.

Dermatol Surg. 2017 Jun;43(6):889-891. doi: 10.1097/DSS.0000000000001055. No abstract available.

PMID:
28541265
5.

Utilization of Optical Coherence Tomography in the Evaluation of Cherry Hemangiomas.

Aldahan AS, Mlacker S, Shah VV, Chen LL, Nouri K, Grichnik JM.

J Drugs Dermatol. 2016 Jun 1;15(6):713-4.

PMID:
27272077
6.

Molecular machines mitigate melanoma.

Hughes OB, Grichnik JM.

Dermatol Ther. 2016 Nov;29(6):397. doi: 10.1111/dth.12360. Epub 2016 May 5. No abstract available.

PMID:
27146009
7.

Acral melanocytic lesions in the United States: Prevalence, awareness, and dermoscopic patterns in skin-of-color and non-Hispanic white patients.

Madankumar R, Gumaste PV, Martires K, Schaffer PR, Choudhary S, Falto-Aizpurua L, Arora H, Kallis PJ, Patel S, Damanpour S, Sanchez MI, Yin N, Chan A, Sanchez M, Polsky D, Kanavy H, Grichnik JM, Stein JA.

J Am Acad Dermatol. 2016 Apr;74(4):724-30.e1. doi: 10.1016/j.jaad.2015.11.035. Epub 2016 Jan 20.

PMID:
26803347
8.

Methods of Melanoma Detection.

Leachman SA, Cassidy PB, Chen SC, Curiel C, Geller A, Gareau D, Pellacani G, Grichnik JM, Malvehy J, North J, Jacques SL, Petrie T, Puig S, Swetter SM, Tofte S, Weinstock MA.

Cancer Treat Res. 2016;167:51-105. doi: 10.1007/978-3-319-22539-5_3. Review.

PMID:
26601859
9.

Conceptual approach to early melanoma detection: models, tools, issues and challenges.

Damanpour S, Grichnik JM.

Melanoma Manag. 2015 Nov;2(4):327-337. doi: 10.2217/mmt.15.24. Epub 2015 Nov 24. Review.

10.

Citrus and melanoma risk: better to consume with dinner?

Bosshardt OP, Grichnik JM.

Dermatol Ther. 2016 May;29(3):211. doi: 10.1111/dth.12294. Epub 2015 Oct 5. No abstract available.

PMID:
26439189
11.

Molecular diagnosis of melanoma-have we arrived?

Bordelon JR, Grichnik JM.

Dermatol Ther. 2015 Nov-Dec;28(6):405. doi: 10.1111/dth.12243. Epub 2015 May 27. No abstract available.

PMID:
26031627
12.

The cell of origin of acral melanomas may be hiding in the sweat glands.

Grichnik JM.

Dermatol Ther. 2015 Mar-Apr;28(2):105-6. doi: 10.1111/dth.12184. Epub 2014 Nov 11. No abstract available.

PMID:
25832467
13.

TGF-β may control the switch between tumorigenic growth and "stem cell/mesenchymal" potentially drug-resistant states.

Bordelon JR, Grichnik JM.

Dermatol Ther. 2015 May-Jun;28(3):177-8. doi: 10.1111/dth.12199. Epub 2015 Feb 3. No abstract available.

PMID:
25649199
14.

Melanomagenesis: multifaceted attacks on the genome.

Bordelon JR, Sanchez MI, Grichnik JM.

Exp Dermatol. 2015 Mar;24(3):175-6. doi: 10.1111/exd.12600. Epub 2015 Jan 22. No abstract available.

PMID:
25421308
15.

Addressing the knowledge gap in clinical recommendations for management and complete excision of clinically atypical nevi/dysplastic nevi: Pigmented Lesion Subcommittee consensus statement.

Kim CC, Swetter SM, Curiel-Lewandrowski C, Grichnik JM, Grossman D, Halpern AC, Kirkwood JM, Leachman SA, Marghoob AA, Ming ME, Nelson KC, Veledar E, Venna SS, Chen SC.

JAMA Dermatol. 2015 Feb;151(2):212-8. doi: 10.1001/jamadermatol.2014.2694. Review.

PMID:
25409291
16.

Sildenafil may elevate melanoma risk.

Grichnik JM.

Dermatol Ther. 2014 Sep-Oct;27(5):313. doi: 10.1111/dth.12162. Epub 2014 Aug 4. No abstract available.

PMID:
25285874
17.

Enhancing techniques to evaluate tumor margins.

Sode T, Cao T, Elgart GW, Jiménez-Acosta F, Grichnik JM.

J Am Acad Dermatol. 2014 Oct;71(4):827-9. doi: 10.1016/j.jaad.2014.05.043. No abstract available.

PMID:
25219704
18.

Do inflammatory pathways drive melanomagenesis?

Schneider SL, Ross AL, Grichnik JM.

Exp Dermatol. 2015 Feb;24(2):86-90. doi: 10.1111/exd.12502. Epub 2014 Nov 11. Review.

PMID:
25041143
19.

Melanoma's high C>T mutation rate: is deamination playing a role?

Sanchez MI, Grichnik JM.

Exp Dermatol. 2014 Aug;23(8):551-2. doi: 10.1111/exd.12436. Epub 2014 Aug 1.

PMID:
24815223
20.

Dermoscopic criteria associated with BRAF and NRAS mutation status in primary cutaneous melanoma.

Pozzobon FC, Puig-Butillé JA, González-Alvarez T, Carrera C, Aguilera P, Alos L, Badenas C, Grichnik JM, Malvehy J, Puig S.

Br J Dermatol. 2014 Oct;171(4):754-9. doi: 10.1111/bjd.13069. Epub 2014 Sep 10.

PMID:
24749938
21.

Dark homogeneous streak dermoscopic pattern correlating with specific KIT mutations in melanoma.

Sanchez MI, Rabinovitz HS, Oliviero MC, Elgart GW, Perez C, Puig S, Malvehy J, Grichnik JM.

JAMA Dermatol. 2014 Jun;150(6):633-9. doi: 10.1001/jamadermatol.2013.8442.

22.

How, and from which cell sources, do nevi really develop?

Grichnik JM, Ross AL, Schneider SL, Sanchez MI, Eller MS, Hatzistergos KE.

Exp Dermatol. 2014 May;23(5):310-3. doi: 10.1111/exd.12363. Epub 2014 Apr 2. Review.

PMID:
24588745
23.

Dermoscopy of acral melanoma: a multicenter study on behalf of the international dermoscopy society.

Braun RP, Thomas L, Dusza SW, Gaide O, Menzies S, Dalle S, Blum A, Argenziano G, Zalaudek I, Kopf A, Rabinovitz H, Oliviero M, Perrinaud A, Cabo H, Pizzichetta M, Pozo L, Langford D, Tanaka M, Saida T, Perusquia Ortiz AM, Kreusch J, De Giorgi V, Piccolo D, Grichnik JM, Kittler H, Puig S, Malvehy J, Seidenari S, Stanganelli I, French L, Marghoob AA.

Dermatology. 2013;227(4):373-80. doi: 10.1159/000356178. Epub 2013 Nov 23.

24.

Malignant melanoma from a nevus of Ota in a pediatric patient with fatal outcome.

Lindsey SF, Sanchez MI, Elgart GW, Milikowski C, Civantos FJ, Goldberg J, Grichnik JM.

J Am Acad Dermatol. 2013 Oct;69(4):e195-7. doi: 10.1016/j.jaad.2013.05.009. No abstract available.

PMID:
24034399
25.

Potential role of meiosis proteins in melanoma chromosomal instability.

Lindsey SF, Byrnes DM, Eller MS, Rosa AM, Dabas N, Escandon J, Grichnik JM.

J Skin Cancer. 2013;2013:190109. doi: 10.1155/2013/190109. Epub 2013 Jun 12.

26.

Germ cell proteins in melanoma: prognosis, diagnosis, treatment, and theories on expression.

Rosa AM, Dabas N, Byrnes DM, Eller MS, Grichnik JM.

J Skin Cancer. 2012;2012:621968. doi: 10.1155/2012/621968. Epub 2012 Nov 12.

27.

Influence of time on dermoscopic diagnosis and management.

Jaimes N, Dusza SW, Quigley EA, Braun RP, Puig S, Malvehy J, Kittler H, Rabinovitz HS, Oliviero MC, Soyer HP, Grichnik JM, Korzenko A, Cabo H, Carlos-Ortega B, Ahlgrimm-Siess V, Kopf AW, Marghoob AA.

Australas J Dermatol. 2013 May;54(2):96-104. doi: 10.1111/ajd.12001. Epub 2012 Nov 29.

PMID:
23190378
28.

Diagnostic role of chromosomal instability in melanoma.

Dabas N, Byrnes DM, Rosa AM, Eller MS, Grichnik JM.

J Skin Cancer. 2012;2012:914267. doi: 10.1155/2012/914267. Epub 2012 Oct 18.

29.

Confocal microscopy of challenging dermoscopic diagnoses.

Sanchez MI, Rabinovitz HS, Oliverio MC, Elgart GW, Grichnik JM.

Arch Dermatol. 2012 Oct;148(10):1224. doi: 10.1001/archdermatol.2012.2538. No abstract available.

PMID:
23069979
30.

Potential role of human growth hormone in melanoma growth promotion.

Handler MZ, Ross AL, Shiman MI, Elgart GW, Grichnik JM.

Arch Dermatol. 2012 Oct;148(10):1179-82. doi: 10.1001/archdermatol.2012.2149.

PMID:
23069955
31.

Nevogenesis: a benign metastatic process?

Ross AL, Sanchez MI, Grichnik JM.

ISRN Dermatol. 2011;2011:813513. doi: 10.5402/2011/813513. Epub 2011 Apr 5.

32.

Nevus senescence.

Ross AL, Sanchez MI, Grichnik JM.

ISRN Dermatol. 2011;2011:642157. doi: 10.5402/2011/642157. Epub 2011 Jun 22.

33.

Survival is not the only valuable end point in melanoma screening.

Curiel-Lewandrowski C, Kim CC, Swetter SM, Chen SC, Halpern AC, Kirkwood JM, Leachman SA, Marghoob AA, Ming ME, Grichnik JM; Melanoma Prevention Working Group—Pigmented Skin Lesion Sub-Committee.

J Invest Dermatol. 2012 May;132(5):1332-7. doi: 10.1038/jid.2012.3. Epub 2012 Feb 16. Review. No abstract available.

34.

Local actions of thyrotropin-releasing hormone regulate hair color.

Dosal J, Grichnik JM, Kirsner RS.

J Invest Dermatol. 2011 Dec;131(12):2340. doi: 10.1038/jid.2011.338. No abstract available.

35.

Genomic instability in cultured stem cells: associated risks and underlying mechanisms.

Ross AL, Leder DE, Weiss J, Izakovic J, Grichnik JM.

Regen Med. 2011 Sep;6(5):653-62. doi: 10.2217/rme.11.44.

PMID:
21916599
36.

Guidelines of care for the management of primary cutaneous melanoma. American Academy of Dermatology.

Bichakjian CK, Halpern AC, Johnson TM, Foote Hood A, Grichnik JM, Swetter SM, Tsao H, Barbosa VH, Chuang TY, Duvic M, Ho VC, Sober AJ, Beutner KR, Bhushan R, Smith Begolka W; American Academy of Dermatology.

J Am Acad Dermatol. 2011 Nov;65(5):1032-47. doi: 10.1016/j.jaad.2011.04.031. Epub 2011 Aug 25.

PMID:
21868127
37.

Reflectance confocal microscopic features of dermatophytes, scabies, and demodex.

Slutsky JB, Rabinovitz H, Grichnik JM, Marghoob AA.

Arch Dermatol. 2011 Aug;147(8):1008. doi: 10.1001/archdermatol.2011.193. No abstract available.

PMID:
21844478
38.

Dermoscopy of scalp tumours: a multi-centre study conducted by the international dermoscopy society.

Stanganelli I, Argenziano G, Sera F, Blum A, Ozdemir F, Karaarslan IK, Piccolo D, Peris K, Kirchesch H, Bono R, Pizzichetta MA, Gasparini S, Braun RP, Correia O, Thomas L, Zaballos P, Puig S, Malvehy J, Scalvenzi M, Rabinovitz H, Bergamo A, Pellacani G, Longo C, Pavlovic M, Rosendahl C, Hofmann-Wellenhof R, Cabo H, Marghoob AA, Langford D, Astorino S, Manganoni AM, Gourhant JY, Keir J, Grichnik JM, Fumo G, Dong H, Sortino Rachou AM, Ferrara G, Zalaudek I.

J Eur Acad Dermatol Venereol. 2012 Aug;26(8):953-63. doi: 10.1111/j.1468-3083.2011.04188.x. Epub 2011 Jul 26.

PMID:
21790795
39.

Molecular nevogenesis.

Ross AL, Sanchez MI, Grichnik JM.

Dermatol Res Pract. 2011;2011:463184. doi: 10.1155/2011/463184. Epub 2011 Apr 6.

40.

Age-dependent differences in growth curves for distinct melanocytic nevus subsets.

Grichnik JM.

Arch Dermatol. 2011 Jun;147(6):731-2. doi: 10.1001/archdermatol.2011.134. No abstract available.

PMID:
21690539
41.

What is the oncologic risk of stem cell treatment for heart disease?

Hatzistergos KE, Blum A, Ince T, Grichnik JM, Hare JM.

Circ Res. 2011 May 27;108(11):1300-3. doi: 10.1161/CIRCRESAHA.111.246611. No abstract available.

42.

Activation of Notch1 signaling in stromal fibroblasts inhibits melanoma growth by upregulating WISP-1.

Shao H, Cai L, Grichnik JM, Livingstone AS, Velazquez OC, Liu ZJ.

Oncogene. 2011 Oct 20;30(42):4316-26. doi: 10.1038/onc.2011.142. Epub 2011 Apr 25.

PMID:
21516124
43.

Stratum corneum RNA levels are diagnostic for melanoma.

Grichnik JM.

Br J Dermatol. 2011 Apr;164(4):693-4. doi: 10.1111/j.1365-2133.2011.10283.x. No abstract available.

PMID:
21457197
44.

Unrecognized sex-specific stress and behavior differences in patients with melanoma.

Grichnik JM.

Arch Dermatol. 2011 Feb;147(2):186. doi: 10.1001/archdermatol.2010.432. No abstract available.

PMID:
21339446
45.

The dermoscopical and histopathological patterns of nevi correlate with the frequency of BRAF mutations.

Zalaudek I, Guelly C, Pellacani G, Hofmann-Wellenhof R, Trajanoski S, Kittler H, Scope A, Marghoob AA, Longo C, Leinweber B, Ferrara G, Saida T, Grichnik JM, Argenziano G, Becker JC.

J Invest Dermatol. 2011 Feb;131(2):542-5. doi: 10.1038/jid.2010.332. Epub 2010 Nov 11. No abstract available.

46.

Modified watershed technique and post-processing for segmentation of skin lesions in dermoscopy images.

Wang H, Moss RH, Chen X, Stanley RJ, Stoecker WV, Celebi ME, Malters JM, Grichnik JM, Marghoob AA, Rabinovitz HS, Menzies SW, Szalapski TM.

Comput Med Imaging Graph. 2011 Mar;35(2):116-20. doi: 10.1016/j.compmedimag.2010.09.006. Epub 2010 Oct 20.

47.

The performance of MelaFind: a prospective multicenter study.

Monheit G, Cognetta AB, Ferris L, Rabinovitz H, Gross K, Martini M, Grichnik JM, Mihm M, Prieto VG, Googe P, King R, Toledano A, Kabelev N, Wojton M, Gutkowicz-Krusin D.

Arch Dermatol. 2011 Feb;147(2):188-94. doi: 10.1001/archdermatol.2010.302. Epub 2010 Oct 18.

PMID:
20956633
48.

Watershed segmentation of dermoscopy images using a watershed technique.

Wang H, Chen X, Moss RH, Stanley RJ, Stoecker WV, Celebi ME, Szalapski TM, Malters JM, Grichnik JM, Marghoob AA, Rabinovitz HS, Menzies SW.

Skin Res Technol. 2010 Aug;16(3):378-84. doi: 10.1111/j.1600-0846.2010.00445.x.

49.

Accurate identification of proliferative index in melanocytic neoplasms with Melan-A/Ki-67 double stain.

Puri PK, Valdes CL, Burchette JL, Grichnik JM, Turner JW, Selim MA.

J Cutan Pathol. 2010 Sep;37(9):1010-2. doi: 10.1111/j.1600-0560.2009.01487.x. Epub 2009 Dec 8. No abstract available.

PMID:
20002650
50.

An improved objective evaluation measure for border detection in dermoscopy images.

Celebi ME, Schaefer G, Iyatomi H, Stoecker WV, Malters JM, Grichnik JM.

Skin Res Technol. 2009 Nov;15(4):444-50. doi: 10.1111/j.1600-0846.2009.00387.x.

Supplemental Content

Loading ...
Support Center